Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature

References

• Akpan, A. and Morgan, R., 2002. Oral candidiasis. Postgraduate Medical Journal, 78 (922), 455–459.
   PubMed Web of Science ®Google Scholar
• Barasch, A. and Griffin, A. V., 2008. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiology, 3 (3), 265–269.
   PubMed Web of Science ®Google Scholar
• Bassetti, M., Mikulska, M., and Viscoli, C., 2010. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Critical Care, 14 (6), 244.
   PubMed Web of Science ®Google Scholar
• Bennett, J.E., Dolin, R., and Blaser, M.J., 2019. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier.
   Google Scholar
• Brunton, L.L., 2011. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. The McGraw-Hill Companies, Inc.
   Google Scholar
• Casneuf, J., et al., 1980. Oral thrush in children treated with miconazole gel. Mykosen, 23 (2), 75–78.
   PubMedGoogle Scholar
• Chayachinda, C., 2022. Experience of using the vaginal suppository combining metronidazole and miconazole in Siriraj Hospital. In: Pattanachindakul B, et al., eds. OB-GYN in practice 2022, 303–306.
   Google Scholar
• Choo, Z.W., et al., 2010. A comparative histopathological study of systemic candidiasis in association with experimentally induced breast cancer. Oncology Letters, 1 (1), 215–222.
   PubMed Web of Science ®Google Scholar
• David, L.M., Walzman, M., and Rajamanoharan, S., 1997. Genital colonisation and infection with candida in heterosexual and homosexual males. Genitourinary Medicine, 73 (5), 394–396.
   PubMedGoogle Scholar
• Doering, P.L. and Santiago, T.M., 1990. Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens. DICP, 24 (11), 1078–1083.
   PubMedGoogle Scholar
• Donders, G.G., et al., 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. British Journal of Gynecology, 109 (1), 34–43.
   Web of Science ®Google Scholar
• Edwards, J.E., Jr., et al., 2018. A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis—a phase 2 randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases, 66 (12), 1928–1936.
   PubMed Web of Science ®Google Scholar
• Eliot, B.W., Howat, R.C., and Mack, A.E., 1979. A comparison between the effects of nystatin, clotrimazole and miconazole on vaginal candidiasis. British Journal of Obstetrics and Gynaecology, 86 (7), 572–577.
   PubMedGoogle Scholar
• Erdogan, A. and Rao, S.S., 2015. Small intestinal fungal overgrowth. Current Gastroenterology Reports, 17 (4), 16.
   PubMedGoogle Scholar
• Falagas, M.E., Betsi, G.I., and Athanasiou, S., 2006. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy, 58 (2), 266–272.
   PubMed Web of Science ®Google Scholar
• Ferris, D.G., et al., 2002. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstetrics and Gynecology, 99 (3), 419–425.
   PubMed Web of Science ®Google Scholar
• Fothergill, A.W., 2006. Miconazole: a historical perspective. Expert Review of anti-Infective Therapy, 4 (2), 171–175.
   PubMedGoogle Scholar
• Francois, I.E.J.A., et al., 2006. Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans. Anti-Infective Agents in Medicinal Chemistry, 5, 3–13.
   Google Scholar
• Goehring, R.V., 2008. Mims’ medical microbiology. 4th ed. Mosby Elsevier.
   Google Scholar
• Hay, R.J., 1996. Yeast infections. Dermatologic Clinics, 14 (1), 113–124.
   PubMed Web of Science ®Google Scholar
• Hay, R., 2018. Therapy of skin, hair and nail fungal infections. Journal of Fungi, 4 (3), 99.
   Web of Science ®Google Scholar
• Hidalgo, J.A. and Vazquez, J.A., 2020. Candidiasis: clinical presentation. Medscape. Available from: https://emedicine.medscape.com/article/213853-clinical.
   Google Scholar
• Hillier, S.L. and Lau, R.J., 1997. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clinical Infectious Diseases, 25 (Suppl. 2), S123–S126.
   PubMed Web of Science ®Google Scholar
• Hoppe, J.E., 1997. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. Pediatric Infectious Disease Journal, 16, 288–293.
   PubMed Web of Science ®Google Scholar
• Ivanov, M., Ćirić, A., and Stojković, D., 2022. Emerging antifungal targets and strategies. International Journal of Molecular Sciences, 23 (5), 2756.
   PubMed Web of Science ®Google Scholar
• Jartarkar, S.R., et al., 2021. Pathogenesis, immunology and management of dermatophytosis. Journal of Fungi, 8 (1), 39.
   Web of Science ®Google Scholar
• Jurden, L., et al., 2012. Clinical inquiries. Can probiotics safely prevent recurrent vaginitis? Journal of Family Practice, 61 (6), 357, 368.
   PubMed Web of Science ®Google Scholar
• Kaur, N., et al., 2021. A review on antifungal efficiency of plant extracts entrenched polysaccharide-based nanohydrogels. Nutrients, 13 (6), 2055.
   PubMed Web of Science ®Google Scholar
• Kobayashi, D., et al., 2002. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrobial Agents and Chemotherapy, 46 (10), 3113–3117.
   PubMed Web of Science ®Google Scholar
• Lansdorp, D., et al., 1999. Potentiation of acenocoumarol during vaginal administration of miconazole. British Journal of Clinical Pharmacology, 47 (2), 225–226.
   PubMed Web of Science ®Google Scholar
• Lynch, D.P., 1994. Oral candidiasis. History, classification, and clinical presentation. Oral Surgery, Oral Medicine, and Oral Pathology, 78 (2), 189–193.
   PubMedGoogle Scholar
• Mårdh, P.A., Novikova, N., and Stukalova, E., 2003. Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis. British Journal of Gynecology, 110 (10), 934–937.
   Web of Science ®Google Scholar
• Martens, M.G., et al., 2022. Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections. American Journal of Obstetrics and Gynecology, 227 (6), 880.e1–880.e11.
   PubMed Web of Science ®Google Scholar
• Martins, N., et al., 2014. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia, 177 (5–6), 223–240.
   PubMed Web of Science ®Google Scholar
• Mulley, A.G. and Goroll, A.H., 2006. Primary care medicine: office evaluation and management of the adult patient. Wolters Kluwer Health.
   Google Scholar
• Nwokolo, N.C. and Boag, F.C., 2000. Chronic vaginal candidiasis. Management in the postmenopausal patient. Drugs & Aging, 16 (5), 335–339.
   PubMed Web of Science ®Google Scholar
• Nyirjesy, P. and Sobel, J.D., 2013. Genital mycotic infections in patients with diabetes. Postgraduate Medicine, 125 (3), 33–46.
   PubMed Web of Science ®Google Scholar
• Odds, F.C., 1987. Candida infections: an overview. Critical Reviews in Microbiology, 15 (1), 1–5.
   PubMed Web of Science ®Google Scholar
• Patil, S., et al., 2015. Clinical appearance of oral candida infection and therapeutic strategies. Frontiers in Microbiology, 6, 1391.
   PubMed Web of Science ®Google Scholar
• Poojary, S.A., 2017. Topical antifungals: a review and their role in current management of dermatophytoses. Clinical Dermatology Review, 1, S24–S29.
   Google Scholar
• Rachapromma, P. and Chayachinta, C., 2022. Care for women with acute vaginal candidiasis. Siriraj Medical Bulletin, 15 (2), 107–113.
   Google Scholar
• Redding, S.W., et al., 1999. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. Journal of Clinical Microbiology, 37 (12), 3896–3900.
   PubMed Web of Science ®Google Scholar
• Ridzuan, P.M., et al., 2019. Mini review on dermatomycosis. Journal of Science and Mathematics Letters, 8, 6–15.
   Google Scholar
• Sawyer, P.R., et al., 1975. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs, 9 (6), 406–423.
   PubMed Web of Science ®Google Scholar
• Saxon, C., et al., 2020. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019). International Journal of STD & AIDS, 31 (12), 1124–1144.
   PubMed Web of Science ®Google Scholar
• Schiefer, H.G., 1997. Mycoses of the urogenital tract. Mycoses, 40 (Suppl. 2), 33–36.
   PubMed Web of Science ®Google Scholar
• Schwebke, J.R., et al., 2022. Ibrexafungerp versus placebo for vulvovaginal candidiasis treatment: a phase 3, randomized, controlled superiority trial (VANISH 303). Clinical Infectious Diseases, 74 (11), 1979–1985.
   PubMed Web of Science ®Google Scholar
• Sobel, J.D., 1994. Controversial aspects in the management of vulvovaginal candidiasis. Journal of the American Academy of Dermatology, 31 (3 Pt 2), S10–S13.
   PubMed Web of Science ®Google Scholar
• Sobel, J.D., 1997. Vaginitis. New England Journal of Medicine, 337 (26), 1896–1903.
   PubMed Web of Science ®Google Scholar
• Sobel, J.D., et al., 1998. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology, 178 (2), 203–211.
   PubMed Web of Science ®Google Scholar
• Srikumar, C. and Nagaraja, H., 2011. A comprehensive review of the occurrence and management of systemic candidiasis as an opportunistic infection. Microbiology Journal, 1, 1–7.
   Google Scholar
• Thevissen, K., et al., 2007. Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast. Journal of Biological Chemistry, 282 (30), 21592–21597.
   PubMed Web of Science ®Google Scholar
• Tobin, M.J., 1995. Vulvovaginal candidiasis: topical vs. oral therapy. American Family Physician, 51 (7), 1715–1720, 1723–1724.
   PubMed Web of Science ®Google Scholar
• Vanden Bossche, H., et al., 1990. Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes. Mycoses, 33 (7–8), 335–352.
   PubMed Web of Science ®Google Scholar
• Vermitsky, J.P., et al., 2008. Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. Journal of Clinical Microbiology, 46 (4), 1501–1503.
   PubMed Web of Science ®Google Scholar
• Walsh, T.J., et al., 1996. Deep mycoses. In: Baron S, ed. Baron’s medical microbiology. 4th ed. University of Texas Medical Branch.
   Google Scholar
• Wang, Z.K., et al., 2014. Review article: fungal microbiota and digestive diseases. Alimentary Pharmacology & Therapeutics, 39 (8), 751–766.
   PubMed Web of Science ®Google Scholar
• Warren, T.R.N., 2010. Is it a yeast infection? WebMD. Available from: https://www.webmd.com/women/features/is-it-yeast-infection.
   Google Scholar
• Workowski, K.A. and Bachmann, L.H., 2022. Centers for disease control and prevention’s sexually transmitted diseases infection guidelines. Clinical Infectious Diseases, 74 (74 Suppl. 2), S89–S94.
   PubMed Web of Science ®Google Scholar
• Workowski, K.A., et al., 2021. Sexually transmitted infections treatment guidelines, 2021. Morbidity and Mortality Weekly Report. Recommendations and Reports, 70 (4), 1–187.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Yin, M., and Zhang, L.J., 2019. Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis. Cells, 8 (8), 807.
   PubMed Web of Science ®Google Scholar